Atlas Trials

Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.

Clinical trial NCT07133776 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07133776
Sponsor
The Affiliated Hospital of Xuzhou Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Epstein-Barr Virus (EBV) InfectionPD-1 InhibitorTenofovirChidamideLenalidomide
Start date
2025-09-01
Primary completion
2027-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.